US Stock MarketDetailed Quotes

APTO Aptose Biosciences

Watchlist
  • 1.1900
  • -0.0200-1.65%
Close May 2 16:00 ET
19.34MMarket Cap-156P/E (TTM)

About Aptose Biosciences Company

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Company Profile

SymbolAPTO
Company NameAptose Biosciences
Listing DateOct 23, 2014
Founded1986
CEODr. William G. Rice, PhD
MarketNASDAQ
Employees42
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address251 Consumers Road,Suite 1105
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM2J 4R3
Phone1-647-479-9828
Websitehttp://www.aptose.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William G. Rice, PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 1.86M
  • Fletcher Payne
  • Principal Accounting Officer, Senior Vice President, Chief Financial Officer and Chief Business Officer
  • 922.38K
  • Philippe Ledru
  • Senior Vice President and Chief Commercial Officer
  • 1.04M
  • Dr. Rafael Bejar, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.20M
  • Dr. Denis R. Burger,PhD
  • Lead Independent Director
  • 176.89K
  • Dr. Erich M. Platzer, M.D.,PhD
  • Independent Director
  • 121.89K
  • Carol Gail Ashe
  • Independent Director
  • 124.39K
  • Dr. Mark D. Vincent, M.D.
  • Independent Director
  • 120.95K
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 45.29K
  • Warren Whitehead
  • Independent Director
  • 125.95K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg